Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis

Necroptosis, or caspase-independent programmed cell death, is known to be involved in various pathological conditions, such as ischemia/reperfusion injury, myocardial infarction, atherosclerosis, and inflammatory bowel diseases. Although several inhibitors of necroptosis have been identified, none o...

Full description

Bibliographic Details
Main Authors: Eun-Jung In, Yuno Lee, Sushruta Koppula, Tae-Yeon Kim, Jun-Hyuk Han, Kwang-Ho Lee, Tae-Bong Kang
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/23/11/2884
id doaj-904a0ce26c294682bfaefbd73cbef5d2
record_format Article
spelling doaj-904a0ce26c294682bfaefbd73cbef5d22020-11-24T21:50:21ZengMDPI AGMolecules1420-30492018-11-012311288410.3390/molecules23112884molecules23112884Identification and Characterization of NTB451 as a Potential Inhibitor of NecroptosisEun-Jung In0Yuno Lee1Sushruta Koppula2Tae-Yeon Kim3Jun-Hyuk Han4Kwang-Ho Lee5Tae-Bong Kang6BK21PLUS Glocal Education Program of Nutraceuticals Development, Department of Applied Life Science, Graduate School, Konkuk University, Chungju 27478, KoreaKorea Chemical Bank, Korea Research Institute of Chemical Technology, Daejeon 34114, KoreaDepartment of Biotechnology, College of Biomedical &amp; Health Science, Research Institute of Inflammatory Diseases, 268 Chungwon-daero, Chungju 27478, KoreaBK21PLUS Glocal Education Program of Nutraceuticals Development, Department of Applied Life Science, Graduate School, Konkuk University, Chungju 27478, KoreaBK21PLUS Glocal Education Program of Nutraceuticals Development, Department of Applied Life Science, Graduate School, Konkuk University, Chungju 27478, KoreaBK21PLUS Glocal Education Program of Nutraceuticals Development, Department of Applied Life Science, Graduate School, Konkuk University, Chungju 27478, KoreaDepartment of Biotechnology, College of Biomedical &amp; Health Science, Research Institute of Inflammatory Diseases, 268 Chungwon-daero, Chungju 27478, KoreaNecroptosis, or caspase-independent programmed cell death, is known to be involved in various pathological conditions, such as ischemia/reperfusion injury, myocardial infarction, atherosclerosis, and inflammatory bowel diseases. Although several inhibitors of necroptosis have been identified, none of them are currently in clinical use. In the present study, we identified a new compound, 4-({[5-(4-aminophenyl)-4-ethyl-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-<i>N</i>-(1,3-thiazol-2-yl) benzamide (NTB451), with significant inhibitory activity on the necroptosis induced by various triggers, such as tumor necrosis factor-&#945; (TNF-&#945;) and toll-like receptor (TLR) agonists. Mechanistic studies revealed that NTB451 inhibited phosphorylation and oligomerization of mixed lineage kinase domain like (MLKL), and this activity was linked to its inhibitory effect on the formation of the receptor interacting serine/threonine-protein kinase 1 (RIPK1)-RIPK3 complex. Small interfering RNA (siRNA)-mediated RIPK1 knockdown, drug affinity responsive target stability assay, and molecular dynamics (MD) simulation study illustrated that RIPK1 is a specific target of NTB451. Moreover, MD simulation showed a direct interaction of NTB451 and RIPK1. Further experiments to ensure that the inhibitory effect of NTB451 was restricted to necroptosis and NTB451 had no effect on nuclear factor-&#954;B (NF-&#954;B) activation or apoptotic cell death upon triggering with TNF-&#945; were also performed. Considering the data obtained, our study confirmed the potential of NTB451 as a new necroptosis inhibitor, suggesting its therapeutic implications for pathological conditions induced by necroptotic cell death.https://www.mdpi.com/1420-3049/23/11/2884necroptosisinhibitorNTB451RIPK1
collection DOAJ
language English
format Article
sources DOAJ
author Eun-Jung In
Yuno Lee
Sushruta Koppula
Tae-Yeon Kim
Jun-Hyuk Han
Kwang-Ho Lee
Tae-Bong Kang
spellingShingle Eun-Jung In
Yuno Lee
Sushruta Koppula
Tae-Yeon Kim
Jun-Hyuk Han
Kwang-Ho Lee
Tae-Bong Kang
Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
Molecules
necroptosis
inhibitor
NTB451
RIPK1
author_facet Eun-Jung In
Yuno Lee
Sushruta Koppula
Tae-Yeon Kim
Jun-Hyuk Han
Kwang-Ho Lee
Tae-Bong Kang
author_sort Eun-Jung In
title Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
title_short Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
title_full Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
title_fullStr Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
title_full_unstemmed Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis
title_sort identification and characterization of ntb451 as a potential inhibitor of necroptosis
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2018-11-01
description Necroptosis, or caspase-independent programmed cell death, is known to be involved in various pathological conditions, such as ischemia/reperfusion injury, myocardial infarction, atherosclerosis, and inflammatory bowel diseases. Although several inhibitors of necroptosis have been identified, none of them are currently in clinical use. In the present study, we identified a new compound, 4-({[5-(4-aminophenyl)-4-ethyl-4H-1,2,4-triazol-3-yl]sulfanyl}methyl)-<i>N</i>-(1,3-thiazol-2-yl) benzamide (NTB451), with significant inhibitory activity on the necroptosis induced by various triggers, such as tumor necrosis factor-&#945; (TNF-&#945;) and toll-like receptor (TLR) agonists. Mechanistic studies revealed that NTB451 inhibited phosphorylation and oligomerization of mixed lineage kinase domain like (MLKL), and this activity was linked to its inhibitory effect on the formation of the receptor interacting serine/threonine-protein kinase 1 (RIPK1)-RIPK3 complex. Small interfering RNA (siRNA)-mediated RIPK1 knockdown, drug affinity responsive target stability assay, and molecular dynamics (MD) simulation study illustrated that RIPK1 is a specific target of NTB451. Moreover, MD simulation showed a direct interaction of NTB451 and RIPK1. Further experiments to ensure that the inhibitory effect of NTB451 was restricted to necroptosis and NTB451 had no effect on nuclear factor-&#954;B (NF-&#954;B) activation or apoptotic cell death upon triggering with TNF-&#945; were also performed. Considering the data obtained, our study confirmed the potential of NTB451 as a new necroptosis inhibitor, suggesting its therapeutic implications for pathological conditions induced by necroptotic cell death.
topic necroptosis
inhibitor
NTB451
RIPK1
url https://www.mdpi.com/1420-3049/23/11/2884
work_keys_str_mv AT eunjungin identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT yunolee identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT sushrutakoppula identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT taeyeonkim identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT junhyukhan identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT kwangholee identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
AT taebongkang identificationandcharacterizationofntb451asapotentialinhibitorofnecroptosis
_version_ 1725884654500708352